Article

pubs.acs.org/joc

Rhodium-Catalyzed Dehydrogenative Coupling of
Phenylheteroarenes with Alkynes or Alkenes
Tomonori Iitsuka,† Koji Hirano,† Tetsuya Satoh,*,†,‡ and Masahiro Miura*,†
†
Department of Applied Chemistry, Faculty of Engineering, Osaka University, Suita, Osaka 565-0871, Japan
‡
JST, ACT-C, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
*S Supporting Information

ABSTRACT: Benzo-fused tri-
to heptacyclic heteroarenes were
eﬀectively constructed by the rhodium-catalyzed dehydrogenative
coupling of phenylheteroarenes with alkynes. Using alkenes as
coupling partners, dehydrogenative alkenylation took place selec-
tively on the phenyl moiety of phenylheteroarenes. Several
experiments with deuterium-labeled substrates indicated that double
C−H bond cleavages take place even in the reaction with alkenes.

■ INTRODUCTION

Benzo-fused heteroarene frameworks can be seen in various
ﬁne chemicals including organic materials1 and pharmaceut-
icals.2 Therefore, the development of simple and straightfor-
ward synthetic methods for constructing the fused compounds
has attracted much attention. One of the most promising
procedures is the transition-metal-catalyzed dehydrogenative
coupling of aromatic substrates possessing a heteroatom-
containing directing group with internal alkynes involving
regioselective C−H bond cleavage at the ortho-position of the
directing group.3 So far, numerous reports for constructing
benzo-fused oxygen-, nitrogen-, phosphorus-, and sulfur-
containing heterocycles have been disclosed (Scheme 1a).
Besides such σ-coordinating directing groups, π-electron units
such as alkenyl, alkynyl, aryl, and cyano functions have been
found to act as directing groups for ortho C−H functionaliza-
tion.4 We conceived that more highly fused polycyclic
heteroarenes can be easily prepared if heteroaryl groups can
be employed as directing groups in the dehydrogenative
coupling with alkynes.5 Indeed,
tricyclic naphthothiophene
structures could be constructed by a single treatment of 3-
phenylthiophenes with alkynes under rhodium catalysis.6,7 This
reaction seems to proceed via π-electron-directed C−H bond
cleavage to form a rhodacycle intermediate, alkyne insertion,
and reductive elimination (Scheme 1b, Y = S, Z = CH). We
succeeded in applying this procedure to constructing tri- to
heptacyclic benzo-fused heteroarene derivatives 3 and 4 from
readily available phenyl- or diphenylheteroarenes 1 and alkynes
2. The oxidative coupling of 3-phenylthiophene with alkenes 5
also proceeded smoothly in the presence of a same catalyst
system to form the corresponding 2′-alkenylated product 6
(Scheme 1c). New mechanistic insights were obtained for the
latter reaction by some deuterium-labeling experiments. The

detailed results obtained for these reactions are described
herein.

■ RESULTS AND DISCUSSION
<para sub=“opt”>
The reaction of 3-phenylthiophene (1a) with diphenylacetylene
(2a) was explored to screen the reaction conditions, as shown
in Table S1 (see Supporting Information). The desired
dehydrogenative coupling product, 4,5-diphenylnaphtho[2,1-
b]thiophene (3aa), was obtained in 84% yield by treatment of
1a (0.2 mmol) with 2a (0.1 mmol) in the presence of
[Cp*RhCl2]2 (0.005 mmol), Cu(OAc)2
·H2O (0.2 mmol), and
Cs2CO3 (0.03 mmol), as catalyst, oxidant, and additive,
respectively, in toluene (1 mL) at 125 °C for 7 h under N2
(entry 1 in Table 1). Doubling of the reaction scale did not
aﬀect the reaction eﬃciency (entry 2). Under the optimized
conditions, bis(4-substituted phenyl)acetylenes possessing
electron-donating (2b−e) and -withdrawing (2f−h) groups
also underwent coupling with 1a to give the corresponding
naphthothiophenes 3ab−ah in 54−86% yields (entries 3−9).
The reaction of 1a with di(2-naphthyl)acetylene (2i)
proceeded eﬃciently to produce 4,5-di(2-naphthyl)naphtho-
[2,1-b]thiophene (3ai) in 75% yield (entry 10). Besides
diarylacetylenes, dialkylacetylenes such as 4-octyne (2j) and
8-hexadecyne (2k) also coupled with 1a smoothly to aﬀord
dialkylnaphthothiophenes 3aj and 3ak (entries 11 and 12). The
latter reaction could be readily scaled up to a gram scale. Thus,
from 1a (10 mmol) and 2k (5 mmol), 3ak was obtained in 56%
yield (1.07 g, entry 13). Contrastingly, more functionalized
such as 2,5-dimethyl-3-hexyne-2,5-diol (2l) and
alkynes,
dimethyl acetylenedicarboxylate (2m), did not react with 1a
at all (entries 14 and 15). It is possible that these alkynes
</para>
Received:
January 21, 2015
Published: February 16, 2015

© 2015 American Chemical Society

2804

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Article

Scheme 1. Dehydrogenative Coupling of Arenes Possessing a Directing Group
<para sub=“opt”>
deactivate the catalyst. The reaction of 1a with an unsym-
metrical alkyne, 1-phenyl-1-propyne (2n), produced 5-methyl-
4-phenylnaphthothiophene derivative 3an predominantly,
along with a minor amount of its 4-methyl-5-phenyl derivative
3an′ (entry 16).
</para>
<para sub="scope">
Next, we examined the reactions of variously substituted 3-
phenylthiophenes 1b−i with alkyne 2a or 2j (Scheme 2).
Methyl, methoxy, chloro, phenyl, ﬂuoro, and methoxycarbonyl
substituents on either the phenyl ring or the thiophene ring
were tolerated under standard conditions to furnish 3ba−3da,
3ej, and 3fa−3ia. It is noted that the reaction of 3-[(1,1′-
biphenyl)-4-yl]thiophene (1e) was conducted using 2j, because
the coupling product of 1e with 2a was less soluble in usual
organic solvents to make its isolation diﬃcult. Tetracyclic
anthrathiophene 3ja and benzonaphthothiophene 3ka frame-
works could be readily constructed in the annulations of 3-(2-
naphthyl)thiophene (1j) and 3-phenylbenzothiophene (1k),
respectively. In the latter case, a better product yield was
obtained at 120 °C rather than that at 125 °C. In contrast to
1k, its regioisomer, 2-phenylbenzothiophene (1l), did not show
any reactivity toward 2a, resulting in no formation of 3la.
Treatment of p-di(thiophen-3-yl)benzene (1m) with 2j in a 2:1
ratio gave 1:1 coupling product 3mj in 57% yield, along with a
minor amount of 1:2 coupling product 4mj. The use of 1m and
2j in a 1:2 ratio aﬀorded 4mj exclusively, albeit with a moderate
yield. The reactions of meta-isomer 1n with 2j gave similar
results, providing 3nj and 4nj. A mixture of regioisomers 3oa
and 3oa′ was formed in the reaction of 3,3′-bithiophene with
2a. 3,4-Diphenylthiophene (1p) reacted with 2a in a 1:1
manner under standard conditions to produce 3pa quantita-
tively. Even under conditions using excess 2a, 3pa was formed
predominantly, along with a minor amount of 1:2 coupling
product 4pa. The reaction using 1p and 2j in a 2:1 ratio
similarly gave 3pj almost quantitatively.
In contrast, 3,6-

diphenylthieno[3,2-b]thiophene (3q) reacted with 2k eﬃ-
ciently in a 1:2 manner to selectively form hexacyclic 4qk. 3-
Phenylbenzofuran (1r) coupled with 2a eﬃciently to form 3ra
in 90% yield, while the reaction of 2-phenyl isomer 1s did not
give 3sa at all. The reactions of 2- (1t), 3- (1u), and 4- (1v)
(thiophen-3-yl)pyridines were next examined. Although 1t did
not react with 2a, 1u, and 1v underwent the annulation. In the
case with 1u, a mixture of regioisomers 3ua and 3ua′ was
formed. 6-(Thiophen-3-yl)quinoline (1w) could also be
employed for the annulation with 2a to selectively form
tetracyclic product 3wa. 4-Phenylthiazoles 1x and 1y coupled
with 2a smoothly, in contrast to 5-phenyl isomers 1z and 1aa.
Similar results were obtained in the reactions of phenyloxazoles
1bb−ee.
</para>
<para sub="scope">
We also examined the construction of a molecule possessing
a further expanded π-conjugated system. Thus, benzonaph-
thothiophene 3ko, prepared by the annulative coupling of 1k
with bis(3,4-dimethoxyphenyl)acetylene (2o), was treated in
the presence of an excess amount of FeCl3 in CH2Cl2/CH3NO2
(2:1) at room temperature for 24 h (Scheme 3).8 As a result,
dehydrogenative cyclization took place to produce heptacyclic
7.
</para>
<para sub="scope">
Under similar catalytic conditions, 1a also underwent the
dehydrogenative coupling with alkenes in place of alkynes. As
shown in Table 2, treatment of 1a (0.4 mmol) with various
acrylates 5a−e (0.2 mmol) in the presence of [Cp*RhCl2]2
·H2O (0.4 mmol), and Cs2CO3 (0.06
(0.01 mmol), Cu(OAc)2
mmol) in toluene (2 mL) at 125 °C for 7 h under N2 gave the
corresponding (E)-3-[2-(thiophen-3-yl)phenyl]acrylates 6aa−
6ae in 47−64% yields (entries 1−5). While N,N-dimethylacry-
lamide (5f) did not react at all (entry 6), diethyl vinyl-
phosphonate (5g) coupled with 1a to give 6ag in a moderate
yield (entry 7). Not only these electron-deﬁcient alkenes but
also variously substituted styrenes 5h−n underwent
the
</para>
2805

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Table 1. Reaction of 3-Phenylthiophene (1a) with Alkynes
2a

However, we obtained a contradicting result

Article
<para sub=“ques”>
the 2′-position, alkene
directed C−H bond cleavage at
insertion, and β-hydrogen elimination to form 6 (Scheme 4).
</para>
<para sub="scope">
in our
subsequent study. Thus, in the treatment of C2-deuterated 1a
(1a-d1) with 5h under standard conditions for 2 h, the 2′-
styrylation proceeded accompanied by the loss of C2 deuterium
to form 6ah-d0 (Scheme 5). In addition, no signiﬁcant D/H
exchange was observed in the recovered 1a-d1. These results
indicate that the coupling reaction involves C−H(D) bond
cleavages not only on the phenyl group but also on the
thiophene ring.
</para>
<para sub="scope">
Next, we investigated the source of the hydrogen introduced
at the C2 position of coupling product 6ah in Scheme 5.
Treatment of 1a-d0 with D2O or CD3CO2D in the presence
and absence of 5h resulted in no incorporation of deuterium in
recovered 1a as well as produced 6ah (Schemes 6a−d). Finally,
the C2-deuterium incorporation in 6ah was observed, when
deuterated styrene 5h-d8 was employed. Thus, C2-deuterated
2′-styrylated product 6ah-d8 was obtained upon treatment of 1a
with 5h-d8 (Scheme 6e). In this case, deuterium was not
incorporated in the recovered 1a at all.
</para>
<para sub="scope">
Based on these experimental results, a revised mechanism for
the reaction of 1a with alkene 5 can be proposed (Scheme 7).
Coordination of the thienyl moiety of 1a to a Cp*RhIII center
and subsequent double C−H bond cleavages would occur to
form a ﬁve-membered rhodacycle intermediate A, as in the
reaction with alkynes (Scheme 1b). Then alkene insertion into
the resulting Rh−C bond to form B, β-hydrogen elimination,
and reductive elimination of 6 from C may take place to release
a Cp*RhI species, which is oxidized by CuII to regenerate the
Cp*RhIII. As in the reaction with alkyne 2a (see Table S1,
Supporting Information), the eﬃciency of the reaction of 1a
with 5h was slightly enhanced by the addition of Cs2CO3.
Indeed, the yield of 6ah decreased to 40% in the absence of
Cs2CO3. One of the possible roles of Cs2CO3 seems to be
trapping HX formed during the coupling reaction.
</para>
<para sub="scope">
In addition, two parallel reactions of 1a-d0 and 1a-d1 with 5h
were conducted separately under standard conditions (Scheme
8). The observed KIE value 2.3:1 (kH/kD) in the early stage
suggests that the rate-determining step involves the C−H(D)
bond cleavage at the C2-position of 1a.
</para>
■ CONCLUSIONS

aReaction conditions: 1a (0.4 mmol), 2 (0.2 mmol), [Cp*RhCl2]2
·H2O (0.4 mmol), Cs2CO3 (0.06 mmol) in
(0.01 mmol), Cu(OAc)2
toluene (2 mL) at 125 °C under N2, unless otherwise noted. bUsing
1a (0.2 mmol), 2 (0.1 mmol), [Cp*RhCl2]2 (0.005 mmol),
·H2O (0.2 mmol), Cs2CO3 (0.03 mmol) in toluene (1
Cu(OAc)2
mL). cDetermined by GC. dUsing 1a (10 mmol), 2 (5 mmol),
·H2O (10 mmol), Cs2CO3 (1.5
[Cp*RhCl2]2 (0.25 mmol), Cu(OAc)2
mmol) in toluene (30 mL).
<para sub="scope">
dehydrogenative coupling to form 2′-styrylated products 6ah−
6an (entries 8−14). In addition to styrenes, 2-vinylnaphthalene
(5o) could also be employed for this reaction (entry 15).
</para>
<para sub=“ques”>
The fact that the alkenylation took place selectively at the 2′-
position on the phenyl ring of 1a rather than on the thienyl
moiety seems to support a reaction mechanism proposed in our
involving thiophene π-unit
preliminary communication,6
</para>
We have demonstrated that the dehydrogenative annulation of
phenylheteroarenes with alkynes can be performed eﬃciently
under rhodium catalysis. The procedure allows the ready
construction of various benzo-fused heterocyclic frameworks by
a single treatment. The rhodium catalyst system is also
applicable to the dehydrogenative coupling with alkenes on
the phenyl ring. Work is underway toward further development
of this procedure utilizing other π-electron systems.
■ EXPERIMENTAL SECTION
<para sub=“exp”>
General. 1H and 13C NMR spectra were recorded at 400 and 100
MHz for CDCl3 solutions. HRMS data were obtained by EI using a
double focusing mass spectrometer, unless noted. GC analysis was
carried out using a silicon OV-17 column (i.d. 2.6 mm × 1.5 m). GC-
MS analysis was carried out using a CBP-1 capillary column (i.d. 0.25
mm × 25 m). The structures of all products listed below were
unambiguously determined by 1H and 13C NMR with the aid of NOE,
COSY, HMQC, and HMBC experiments.
Phenylheteroarenes 1b−j,9 1k,l,10 1m,n,11 1p,q,9 1r,12 1s,10 1t−w,9
1x,y,13 1z,aa,14 1cc,15 and 1ee,16 and alkynes 2b−d,17 2e,18 2f,19
2g,h,17 2i,20 and 2o17 were prepared according to published
</para>
2806

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry
Scheme 2. Reaction of (Hetero)arylheteroarenes 1 with Alkyne 2a, 2j, or 2ka

Article

aReaction conditions: 1 (0.4 mmol), 2 (0.2 mmol), [Cp*RhCl2]2 (0.01 mmol), Cu(OAc)2
mL) at 125 °C under N2, unless otherwise noted. bAt 120 °C. cUsing Cu(OAc)2
[Cp*RhCl2]2 (0.02 mmol), Cu(OAc)2
Cu(OAc)2
mmol), and Cs2CO3 (0.06 mmol). gUsing 1 (2 mmol), 2 (1 mmol), [Cp*RhCl2]2 (0.05 mmol), Cu(OAc)2
mmol) in toluene (10 mL). hUsing 1 (0.2 mmol), 2 (0.1 mmol), [Cp*RhCl2]2 (0.005 mmol), Cu(OAc)2
mmol) in toluene (1 mL).

·H2O (0.4 mmol), Cs2CO3 (0.06 mmol) in toluene (2
·H2O (0.8 mmol). dUsing 1 (0.2 mmol), 2 (0.4 mmol),
·H2O (0.8 mmol), and Cs2CO3 (0.12 mmol). eUsing 1 (0.2 mmol), 2 (0.4 mmol), [Cp*RhCl2]2 (0.01 mmol),
·H2O (0.8
·H2O (2 mmol), and Cs2CO3 (0.3
·H2O (0.2 mmol), and Cs2CO3 (0.03

·H2O (0.8 mmol), and Cs2CO3 (0.12 mmol). fUsing 1 (0.2 mmol), 2 (0.4 mmol), [Cp*RhCl2]2 (0.01 mmol), Cu(OAc)2
<para sub=“exp”>
procedures. Phenylheteroarene 1a-d1 was prepared as shown below.
Other starting materials and reagents were commercially available.

Preparation of 1a-d1. 2-Bromo-3-phenylthiophene was prepared
according to published procedures.21 To a solution of 2-bromo-3-
phenylthiophene (3.0 mmol, 720 mg) in Et2O (6 mL) was added a
solution of nBuLi in hexane (1.63 M, 1.9 mL, 3.1 mmol) dropwise at
−78 °C under N2. The reaction mixture was stirred for 0.5 h and

warmed to 0 °C, to which D2O (5 mL) was added slowly. The mixture
was warmed to room temperature and stirred overnight. Then the
reaction mixture was extracted with ethyl acetate (100 mL). The
organic layer was washed by water (100 mL, three times) and dried
over Na2SO4. After evaporation of the solvents under vacuum, C2-
deuterated 3-phenylthiophene (1a-d1) was isolated (338 mg, 70%).
</para>
2807

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Article

Scheme 3. Reaction of 1k with 2o and Further Cyclization

Table 2. Reaction of 3-Phenylthiophene (1a) with Alkenes
5a
<para sub=“exp”>
General Procedure for the Reaction of Phenylheteroarenes
1 with Alkynes 2. To a 20 mL two-necked ﬂask with a reﬂux
condenser, a balloon, and a rubber cup were added phenylheteroarene
1 (0.4 mmol), alkyne 2 (0.2 mmol), [Cp*RhCl2]2 (0.01 mmol, 6 mg),
·H2O (0.4 mmol, 80 mg), Cs2CO3 (0.06 mmol, 20 mg), 1-
Cu(OAc)2
methylnaphthalene (ca. 30 mg) as internal standard, and toluene (2
mL). Then the resulting mixture was stirred under nitrogen at 125 °C
(bath temperature). After cooling, the reaction mixture was extracted
with ethyl acetate (100 mL) and ethylenediamine (2 mL). The organic
layer was washed by water (100 mL, three times) and dried over
Na2SO4. After evaporation of the solvents under vacuum, product 3
was isolated by column chromatography on silica gel using hexane as
eluant. Further puriﬁcation by GPC (gel permeation chromatography)
was performed, if needed.

Reaction of 1a-d1 with 5h-d0 (Scheme 5). To a 20 mL two-
necked ﬂask with a reﬂux condenser, a balloon, and a rubber cup were
added 3-phenylthiophene (1a-d1) (0.4 mmol, 64 mg; 83% D), styrene
(5h-d0) (0.2 mmol, 21 mg), [Cp*RhCl2]2 (0.01 mmol, 6 mg),
·H2O (0.4 mmol, 80 mg), Cs2CO3 (0.06 mmol, 20 mg), 1-
Cu(OAc)2
methylnaphthalene (ca. 30 mg) as internal standard, and toluene (2
mL). Then the resulting mixture was stirred under nitrogen at 125 °C
(bath temperature) for 2 h. After cooling, the reaction mixture was
extracted with ethyl acetate (100 mL) and ethylenediamine (2 mL).
The organic layer was washed by water (100 mL, three times) and
dried over Na2SO4. After evaporation of the solvents under vacuum,
product 6ah-d0 (6 mg, 12%) and 1a-d1 (55 mg, 86%) were isolated by
column chromatography on silica gel using hexane as eluant.

Treatment of 1a-d0 with D2O (Scheme 6a). To a 20 mL two-
necked ﬂask with a reﬂux condenser, a balloon, and a rubber cup were
added 3-phenylthiophene (1a-d0) (0.4 mmol, 64 mg), [Cp*RhCl2]2
·H2O (0.4 mmol, 80 mg), Cs2CO3
(0.01 mmol, 6 mg), Cu(OAc)2
(0.06 mmol, 20 mg), D2O (0.8 mmol, 16 mg) and toluene (2 mL).
Then the resulting mixture was stirred under nitrogen at 125 °C (bath
temperature) for 2 h. After cooling, the reaction mixture was extracted
with ethyl acetate (100 mL) and ethylenediamine (2 mL). The organic
layer was washed by water (100 mL, three times) and dried over
Na2SO4. After evaporation of the solvents under vacuum, product 1a-
d0 (61 mg, 95%) was isolated by column chromatography on silica gel
using hexane as eluant.

Treatment of 1a-d0 with CD3CO2D (Scheme 6b). To a 20 mL
two-necked ﬂask with a reﬂux condenser, a balloon, and a rubber cup
were added 3-phenylthiophene (1a-d0) (0.4 mmol, 64 mg),
·H2O (0.4 mmol, 80
[Cp*RhCl2]2 (0.01 mmol, 6 mg), Cu(OAc)2
mg), Cs2CO3 (0.06 mmol, 20 mg), CD3CO2D (0.8 mmol, 51 mg) and
toluene (2 mL). Then the resulting mixture was stirred under nitrogen
at 125 °C (bath temperature) for 2 h. After cooling, the reaction
mixture was extracted with ethyl acetate (100 mL) and ethylenedi-
</para>
aReaction conditions: 1a (0.4 mmol), 5 (0.2 mmol), [Cp*RhCl2]2
·H2O (0.4 mmol), and Cs2CO3 (0.06 mmol)
(0.01 mmol), Cu(OAc)2
in toluene (2 mL) at 125 °C under N2. bCy = cyclohexyl.

Scheme 4. Previously Proposed Mechanism for the Reaction
of 1a with 5
<para sub=“exp”>
amine (2 mL). The organic layer was washed by water (100 mL, three
times) and dried over Na2SO4. After evaporation of the solvents under
vacuum, product 1a-d0 (61 mg, 96%) was isolated by column
chromatography on silica gel using hexane as eluant.

Reaction of 1a-d0 with 5h-d0 in the Presence of D2O
(Scheme 6c). To a 20 mL two-necked ﬂask with a reﬂux condenser, a
balloon, and a rubber cup were added 3-phenylthiophene (1a-d0) (0.4
mmol, 64 mg), styrene (5h-d0) (0.2 mmol, 21 mg), [Cp*RhCl2]2
</para>
2808

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Scheme 5. Reaction of 1a-d

1 with 5h

Scheme 6. Deuterium Incorporation

Article

aIsolated yield based on the amount of 5h used.
<para sub=“exp”>
·H2O (0.4 mmol, 80 mg), Cs2CO3
(0.01 mmol, 6 mg), Cu(OAc)2
(0.06 mmol, 20 mg), D2O (0.8 mmol, 16 mg), 1-methylnaphthalene
(ca. 30 mg) as internal standard, and toluene (2 mL). Then the
resulting mixture was stirred under nitrogen at 125 °C (bath
temperature) for 2 h. After cooling, the reaction mixture was extracted
with ethyl acetate (100 mL) and ethylenediamine (2 mL). The organic
layer was washed by water (100 mL, three times) and dried over
Na2SO4. After evaporation of the solvents under vacuum, product 6ah-
d0 (22 mg, 42%) and 1a-d0 (37 mg, 58%) were isolated by column
chromatography on silica gel using hexane as eluant.

Reaction of 1a-d0 with 5h-d0 in the Presence of CD3CO2D
(Scheme 6d). To a 20 mL two-necked ﬂask with a reﬂux condenser, a
balloon, and a rubber cup were added 3-phenylthiophene (1a-d0) (0.4
mmol, 64 mg), styrene (5h-d0) (0.2 mmol, 21 mg), [Cp*RhCl2]2
·H2O (0.4 mmol, 80 mg), Cs2CO3
(0.01 mmol, 6 mg), Cu(OAc)2
(0.06 mmol, 20 mg), CD3CO2D (0.8 mmol, 51 mg), 1-
methylnaphthalene (ca. 30 mg) as internal standard, and toluene (2
mL). Then the resulting mixture was stirred under nitrogen at 125 °C
(bath temperature) for 6 h. After cooling, the reaction mixture was
extracted with ethyl acetate (100 mL) and ethylenediamine (2 mL).
The organic layer was washed by water (100 mL, three times) and
dried over Na2SO4. After evaporation of the solvents under vacuum,
product 6ah-d0 (19 mg, 36%) and 1a-d0 (41 mg, 64%) were isolated
by column chromatography on silica gel using hexane as eluant.

Reaction of 1a-d0 with 5h-d8 (Scheme 6e). To a 20 mL two-
necked ﬂask with a reﬂux condenser, a balloon, and a rubber cup were
added 3-phenylthiophene (1a-d0) (0.4 mmol, 64 mg), styrene (5h-d8)
(0.2 mmol, 22 mg; 98% D), [Cp*RhCl2]2 (0.01 mmol, 6 mg),
·H2O (0.4 mmol, 80 mg), Cs2CO3 (0.06 mmol, 20 mg), 1-
Cu(OAc)2
methylnaphthalene (ca. 30 mg) as internal standard, and toluene (2
mL). Then the resulting mixture was stirred under nitrogen at 125 °C
(bath temperature) for 2 h. After cooling, the reaction mixture was
extracted with ethyl acetate (100 mL) and ethylenediamine (2 mL).
The organic layer was washed by water (100 mL, three times) and
dried over Na2SO4. After evaporation of the solvents under vacuum,
product 6ah-d8 (17 mg, 32%) and 1a-d0 (44 mg, 68%) were isolated
by column chromatography on silica gel using hexane as eluant.
Parallel Reactions of 1a-d0 and 1a-d1 (Scheme 8). To a 20 mL
two-necked ﬂask were added 3-phenylthiophene-d0 or −d1 (1a-d0 or
1a-d1) (0.4 mmol), styrene (5h) (0.2 mmol, 21 mg), [Cp*RhCl2]2
·H2O (0.4 mmol, 80 mg), Cs2CO3
(0.01 mmol, 6 mg), Cu(OAc)2
(0.06 mmol, 20 mg), 1-methylnaphthalene (ca. 30 mg) as internal
standard, and toluene (2 mL). The resulting mixture was stirred under
N2 at 125 °C for 0.75 h. GC and GC-MS analyses of the mixture
conﬁrmed formation of 6ah-d0 (14% from 1a-d0; 6% from 1a-d1): kH/
kD = 2.3.
4,5-Diphenylnaphtho[2,1-b]thiophene (3aa):6 mp 189−190
°C (pale yellow powder), 28 mg (84%); 1H NMR (400 MHz, CDCl3)
δ 7.19−7.29 (m, 10H), 7.41−7.46 (m, 1H), 7.58 (d, J = 5.5 Hz, 1H),
7.59−7.63 (m, 1H), 7.67 (d, J = 8.7 Hz, 1H), 8.09 (d, J = 5.5 Hz, 1H),
8.43 (d, J = 7.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 122.3, 123.6,
125.4, 126.1, 126.6, 126.7, 127.2, 127.7, 127.8, 128.0, 128.7, 130.0,
131.3, 131.5, 133.7, 134.8, 135.3, 138.8, 139.8, 139.9; HRMS m/z
Calcd for C24H16S (M+) 336.0973, found 336.0972.
</para>
aIsolated yield based on the amount of 5h used.
<para sub=“exp”>
4,5-Bis(4-methylphenyl)naphtho[2,1-b]thiophene (3ab):6
mp 193−194 °C (brown powder), 63 mg (86%); 1H NMR (400
MHz, CDCl3) δ 2.31 (s, 3H), 2.33 (s, 3H), 7.05−7.08 (m, 6H), 7.17
(d, J = 8.0 Hz, 2H), 7.38−7.42 (m, 1H), 7.54 (d, J = 5.4 Hz, 1H),
7.56−7.60 (m, 1H), 7.67 (d, J = 8.0 Hz, 1H), 8.05 (d, J = 5.5 Hz, 1H),
8.39 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 21.25, 21.30,
122.2, 123.5, 125.3, 126.0, 126.4, 127.9, 128.4 (overlapped), 128.7,
129.8, 131.3, 131.6, 133.7, 134.8, 135.2, 135.9, 136.1, 136.6, 137.1,
140.2; HRMS m/z Calcd for C26H20S (M+) 364.1286, found 364.1291.
</para>
2809

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Scheme 7. Plausible Mechanism for the Reaction of 1a with
5

Scheme 8. Parallel Reactions of 1a-d

0 and 1a-d

1

a

aReaction conditions: 1a (0.4 mmol), 5h (0.2 mmol), [Cp*RhCl2]2
·H2O (0.4 mmol), and Cs2CO3 (0.06 mmol)
(0.01 mmol), Cu(OAc)2
in toluene (2 mL) at 125 °C under N2 for 0.75 h. bGC yield based on
the amount of 5 h used.
<para sub=“exp”>
4,5-Bis[4-(tert-butyl)phenyl]naphtho[2,1-b]thiophene (3ac):6
mp 233−234 °C (pale yellow powder), 59 mg (65%); 1H NMR (400
MHz, CDCl3) δ 1.26 (s, 9H), 1.28 (s, 9H), 7.08 (d, J = 8.4 Hz, 2H),
7.15 (d, J = 8.5 Hz, 2H), 7.20−7.25 (m, 4H), 7.41−7.45 (m, 1H), 7.55
(d, J = 5.4 Hz, 1H), 7.59−7.61 (m, 1H), 7.80 (d, J = 8.0 Hz, 1H), 8.07
(d, J = 5.6 Hz, 1H), 8.41 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 31.25, 31.32, 34.42, 34.44, 122.2, 123.5, 124.3, 124.5, 125.3,
125.9, 126.3, 128.0, 128.7, 129.6, 131.2, 132.3, 133.9, 135.1, 135.2,
135.8, 136.9, 139.8, 149.3, 149.7; HRMS m/z Calcd for C32H32S (M+)
448.2225, found 448.2227.
4,5-Bis(4-methoxyphenyl)naphtho[2,1-b]thiophene (3ad):6
mp 218−220 °C (white powder), 60 mg (76%); 1H NMR (400
MHz, CDCl3) δ 3.78 (s, 3H), 3.80 (s, 3H), 6.77−6.83 (m, 4H), 7.07−
7.13 (m, 2H), 7.17−7.21 (m, 2H), 7.39−7.43 (m, 1H), 7.55 (d, J = 5.4
Hz, 1H), 7.56−7.60 (m, 1H), 7.69 (d, J = 7.3 Hz, 1H), 8.06 (d, J = 5.5
Hz, 1H), 8.39 (d, J = 8.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
55.09, 55.14, 113.2, 113.4, 122.3, 123.5, 125.3, 126.0, 126.4, 127.8,
128.7, 131.1, 131.2, 131.7, 132.45, 132.52, 133.6, 134.56, 135.1, 140.3,
158.2, 158.5; HRMS m/z Calcd for C26H20O2S (M+) 396.1184, found
396.1181.
4,4′-(Naphtho[2,1-b]thiophene-4,5-diyl)bis(N,N-dimethyla-
niline) (3ae). mp 234−236 °C (brown powder), 60 mg (71%); 1H
NMR (400 MHz, CDCl3) δ 2.93 (s, 6H), 2.94 (s, 6H), 6.63 (d, J = 7.4
Hz, 2H), 6.67 (d, J = 8.8 Hz, 2H), 7.07 (d, J = 8.8 Hz, 2H), 7.18 (d, J
= 8.8 Hz, 2H), 7.36−7.41 (m, 1H), 7.51 (d, J = 5.2 Hz, 1H), 7.52−
7.57 (m, 1H), 7.76 (d, J = 8.4 Hz, 1H), 8.04 (d, J = 5.6 Hz, 1H), 8.37
(d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 40.5, 40.6, 111.9,
</para>
Article
<para sub=“exp”>
112.0, 122.2, 123.4, 125.0, 125.6, 126.1, 127.4, 128.1, 128.60, 128.64,
130.8, 132.2, 132.3, 134.0, 134.86, 134.89, 141.0, 149.0, 149.2; HRMS
m/z Calcd for C28H26N2S (M+) 422.1817, found 422.1819.
4,5-Bis(4-bromophenyl)naphtho[2,1-b]thiophene (3af). mp
220−222 °C (white powder), 54 mg (54%); 1H NMR (400 MHz,
CDCl3) δ 7.05 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 8.4 Hz, 2H), 7.40−7.46
(m, 5H), 7.58−7.64 (m, 3H), 8.07 (d, J = 5.5 Hz, 1H), 8.41 (d, J = 8.2
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 121.2, 121.7, 122.4, 123.7,
125.7, 126.5, 126.9, 127.5, 128.8, 130.9, 131.1, 131.5, 131.6, 132.5,
133.0, 133.5, 135,7, 137.5, 138.4, 139.2; HRMS m/z Calcd for
C24H14Br2S (M+) 491.9183, found 491.9185.
1,1′-(Naphtho[2,1-b]thiophene-4,5-diylbis(4,1-phenylene))-
diethanone (3ag). mp 251−252 °C (white powder), 62 mg (62%);
1H NMR (400 MHz, CDCl3) δ 2.58 (s, 3H), 2.60 (s, 3H), 7.31 (d, J =
8.4 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 7.44−7.48 (m, 1H), 7.58 (d, J =
8.2 Hz, 1H), 7.61−7.67 (m, 2H), 7.85−7.89 (m, 4H), 8.10 (d, J = 5.6
Hz, 1H), 8.44 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
26.6 (overlapped), 122.4, 123.8, 125.9, 126.7, 127.2, 127.4, 127.9,
128.3, 128.9, 130.3, 130.6, 131.7, 132.6, 133.7, 135.7, 135.9, 136.0,
138.8, 143.8, 144.4, 197.7, 197.8; HRMS m/z Calcd for C28H20O2S
(M+) 420.1184, found 420.1186.
4,5-Bis[4-(triﬂuoromethyl)phenyl]naphtho[2,1-b]thiophene
(3ah):6 mp 225−226 °C (white powder), 70 mg (74%); 1H NMR
(400 MHz, CDCl3) δ 7.31 (d, J = 7.9 Hz, 2H), 7.37 (d, J = 7.9 Hz,
2H), 7.45−7.49 (m, 1H), 7.52−7.56 (m, 5H), 7.62 (d, J = 5.4 Hz,
1H), 7.64−7.68 (m, 1H), 8.10 (d, J = 5.5 Hz, 1H), 8.44 (d, J = 8.12
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 122.4, 123.8, 124.0 (q, J =
270.5 Hz), 124.1 (q, J = 270.4 Hz), 124.9 (q, J = 3.7 Hz), 125.3 (q, J =
3.6 Hz), 126.0, 126.8, 127.2, 127.3, 129.0, 129.3 (q, J = 32.2 Hz), 129.7
(q, J = 33.3 Hz), 130.3, 130.7, 131.8, 132.4, 133.5,136.1, 138.9, 142.3,
143.0; HRMS m/z Calcd for C26H14F6S (M+) 472.0720,
found
472.0717.
4,5-Di(naphthalen-2-yl)naphtho[2,1-b]thiophene (3ai). mp
215−217 °C (white powder), 65 mg (75%); 1H NMR (400 MHz,
CDCl3) δ 7.33−7.41 (m, 7H), 7.56−7.72 (m, 10H), 7.92 (s, 1H), 8.10
(d, J = 5.6 Hz, 1H), 8.44 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 122.3, 123.6, 125.5, 125.8, 125.9 (overlapped), 126.0, 126.2,
126.8, 127.3, 127.61, 127.63, 127.7, 127.90, 127.92, 128.1 (over-
lapped), 128.9, 129.0, 129.6, 130.5, 131.6, 132.2, 132.4, 132.9, 133.0,
133.8, 134.8, 135.5, 136.4, 137.5, 140.1; HRMS m/z Calcd for C32H20S
(M+) 436.1286, found 436.1283.
4,5-Dipropylnaphtho[2,1-b]thiophene (3aj):6 mp 83−84 °C
(white powder), 21 mg (79%); 1H NMR (400 MHz, CDCl3) δ 1.09−
1.14 (m, 6H), 1.68−1.85 (m, 4H), 3.00−3.04 (m, 2H), 3.09−3.13 (m,
2H), 7.49 (d, J = 5.4 Hz, 1H), 7.51−7.55 (m, 2H), 7.96 (d, J = 5.4 Hz,
1H), 8.07−8.11 (m, 1H), 8.30−8.34 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 14.7 (overlapped), 23.2, 24.4, 30.7, 35.4, 122.6, 124.1, 124.2,
124.9, 125.1, 125.2, 128.7, 130.7, 132.0, 132.2, 134.4, 139.7; HRMS m/
z Calcd for C18H20S (M+) 268.1286, found 268.1288.
4,5-Diheptylnaphtho[2,1-b]thiophene (3ak):6 mp 39−40 °C
(yellow powder), 65 mg (85%); 1H NMR (400 MHz, CDCl3) δ 0.88−
0.92 (m, 6H), 1.32−1.43 (m, 12H), 1.48−1.57 (m, 4H), 1.64−1.80
(m, 4H), 3.00−3.04 (m, 2H), 3.10−3.14 (m, 2H), 7.48 (d, J = 5.4 Hz,
1H), 7.51−7.54 (m, 2H), 7.95 (d, J = 5.4 Hz, 1H), 8.08−8.11 (m,
1H), 8.29−8.33 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1
(overlapped), 22.7 (overlapped), 28.6, 29.1, 29.2, 29.8, 30.2, 30.3, 31.2,
31.8, 31.9, 33.3, 122.6, 124.1, 124.2, 124.9, 125.0, 125.2, 128.7, 130.7,
132.16, 132.23, 134.3, 139.7; HRMS m/z Calcd for C26H36S (M+)
380.2538, found 380.2534.
5-Methyl-4-phenylnaphtho[2,1-b]thiophene (3an):6 mp 69−
71 °C (white powder), 27 mg (50%); 1H NMR (400 MHz, CDCl3) δ
2.55 (s, 3H), 7.43−7.48 (m, 4H), 7.50−7.54 (m, 2H), 7.57−7.65 (m,
2H), 8.00 (d, J = 5.4 Hz, 1H), 8.14−8.17 (m, 1H), 8.37- 8.40 (m, 1H);
13C NMR (100 MHz, CDCl3) δ 16.3, 122.2, 124.0, 125.3, 125.5, 125.6,
125.9, 127.7, 127.8, 128.6, 128.8, 129.6, 131.3, 133.9, 134.1, 140.2,
140.6; HRMS m/z Calcd for C19H14S (M+) 274.0816, found 274.0815.
4-Methyl-5-phenylnaphtho[2,1-b]thiophene (3an′):6 mp
114−116 °C (white powder), 7 mg (12%); 1H NMR (400 MHz,
CDCl3) δ 2.42 (s, 3H), 7.30−7.33 (m, 2H), 7.35−7.39 (m, 1H),
7.46−7.48 (m, 2H), 7.50−7.56 (m, 3H), 7.61 (d, J = 5.4 Hz, 1H), 8.07
</para>
2810

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry
<para sub=“exp”>
(d, J = 5.4 Hz, 1H), 8.36 (d, J = 8.1 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 19.1, 122.7, 123.4, 125.1, 125.29, 125.33, 127.2, 127.3,
127.7, 128.1, 128.4, 130.6, 131.6, 134.97, 134.98, 139.5, 139.6; HRMS
m/z Calcd for C19H14S (M+) 274.0816, found 274.0814.
5,6-Bis(3,4-dimethoxyphenyl)benzo[b]naphtho[1,2-d]-
thiophene (3ko). mp 231−233 °C (pink powder), 254 mg (50%);
1H NMR (400 MHz, CDCl3) δ 3.65 (s, 3H), 3.69 (s, 3H), 3.86 (s,
3H), 3.87 (s, 3H), 6.67−6.98 (m, 6H), 7.43−7.50 (m, 2H), 7.57 (t, J =
7.6 Hz, 1H), 7.71 (t, J = 8.0 Hz, 1H), 7.89 (s, 1H), 7.90 (s, 1H), 8.88
(d, J = 8.4 Hz, 1H), 9.09 (d, J = 8.4 Hz, 1H); 13C NMR (125 MHz,
DMSO-d6, 90 °C) δ 56.61, 56.66, 56.68, 56.7, 112.9, 113.0, 115.9,
117.1, 123.2, 123.8, 123.9, 124.5, 125.5, 125.9, 126.0, 126.2, 127.8,
128.6, 128.8, 130.3, 131.9, 132.6, 133.1, 134.5, 137.1, 137.9, 140.3,
141.6, 149.0, 149.36, 149.4, 149.5; HRMS (APCI) m/z Calcd for
C32H27O4S ([M + H]+) 507.1625, found 507.1624.
7-Methyl-4,5-diphenylnaphtho[2,1-b]thiophene (3ba):6 mp
162−163 °C (white powder), 60 mg (85%); 1H NMR (400 MHz,
CDCl3) δ 2.42 (s, 3H), 7.18−7.29 (m, 10H), 7.43−7.46 (m, 2H), 7.55
(d, J = 5.5 Hz, 1H), 8.05 (d, J = 5.4 Hz, 1H), 8.32 (d, J = 8.3 Hz, 1H);
13C NMR (100 MHz, CDCl3) δ 21.9, 122.2, 123.5, 126.5, 126.6, 126.9,
127.0, 127.1, 127.6, 127.9, 128.1, 130.0, 131.4, 131.6, 133.8, 134.4,
135.0, 135.3, 138.95, 139.03, 140.1; HRMS m/z Calcd for C25H18S
(M+) 350.1129, found 350.1126.
7-Methoxy-4,5-diphenylnaphtho[2,1-b]thiophene (3ca):6 mp
196−197 °C (pale yellow powder), 49 mg (66%); 1H NMR (400
MHz, CDCl3) δ 3.70 (s, 3H), 7.03 (d, J = 2.6 Hz, 1H), 7.18−7.28 (m,
11H), 7.54 (d, J = 5.4 Hz, 1H), 7.99 (d, J = 5.5 Hz, 1H), 8.31 (d, J =
9.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.1, 107.7, 117.2, 122.0,
123.9, 125.1, 126.69, 126.73, 127.1, 127.7, 127.9, 123.0, 131.4, 132.6,
134.1, 134.2, 135.4, 137.9, 138.9, 140.0, 157.2; HRMS m/z Calcd for
C25H18OS (M+) 366.1078, found 366.1080.
7-Chloro-4,5-diphenylnaphtho[2,1-b]thiophene (3da):6 mp
194−195 °C (pale yellow powder), 74 mg (98%); 1H NMR (400
MHz, CDCl3) δ 7.06−7.09 (m, 2H), 7.13−7.21 (m, 8H), 7.44 (q, J =
2.2, 8.7 Hz, 1H), 7.49 (d, J = 5.5 Hz, 1H), 7.56 (d, J = 2.0 Hz, 1H),
7.92 (d, J = 5.5 Hz, 1H), 8.23 (d, J = 8.8 Hz, 1H); 13C NMR (100
MHz, CDCl3) δ 122.1, 125.2, 126.7 (overlapped), 126.99, 127.03,
127.3, 127.4, 127.9, 128.0, 129.8, 131.3, 131.4, 132.4, 134.0, 134.9,
135.1, 138.1, 139.5, 140.0; HRMS m/z Calcd for C24H15ClS (M+)
370.0583, found 370.0586.
7-Phenyl-4,5-dipropylnaphtho[2,1-b]thiophene (3ej). mp
116−117 °C (white powder), 52 mg (76%); 1H NMR (400 MHz,
CDCl3) δ 1.10−1.16 (m, 6H), 1.73−1.86 (m, 4H), 3.02−3.06 (m,
2H), 3.15−3.19 (m, 2H), 7.39 (t, J = 7.6 Hz, 1H), 7.49−7.53 (m, 3H),
7.74 (d, J = 7.2 Hz, 2H), 7.78 (dd, J = 1.6, 8.4 Hz, 1H), 7.97 (d, J = 5.6
Hz, 1H), 8.28 (d, J = 1.2 Hz, 1H), 8.37 (d, J = 8.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 14.7, 14.8, 23.2, 24.5, 30.7, 35.4, 122.6, 123.3,
124.4, 124.65, 124.67, 127.1, 127.5, 127.8, 128.9, 130.9, 132.3, 132.5,
134.2, 137.9, 139.8, 141.9; HRMS m/z Calcd for C24H24S (M+)
344.1599, found 344.1601.
6-Fluoro-4,5-diphenylnaphtho[2,1-b]thiophene (3fa):6 mp
181−183 °C (white powder), 62 mg (87%); 1H NMR (400 MHz,
CDCl3) δ 7.09 (ddd, J = 1.1, 7.7, 13.2 Hz, 1H), 7.14−7.25 (m, 10H),
7.53 (td, J = 4.8, 7.9 Hz, 1H), 7.57 (d, J = 5.4 Hz, 1H), 8.03 (d, J = 5.5
Hz, 1H), 8.22 (d, J = 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
111.7 (d, J = 23.2 Hz), 119.8 (d, J = 4.2 Hz), 120.8 (d, J = 8.6 Hz),
122.5, 126.2, 126.6 (d, J = 9.3 Hz), 126.8, 127.2, 127.4, 127.8, 129.9,
130.2 (d, J = 4.1 Hz), 131.0 (d, J = 3.3 Hz), 131.1 (d, J = 2.3 Hz),
135.0 (d, J = 2.9 Hz), 135.5, 139.3, 140.77, 140.81, 160.2 (d, J = 254.0
Hz); HRMS m/z Calcd for C24H15FS (M+) 354.0878, found 354.0876.
1-Methyl-4,5-diphenylnaphtho[2,1-b]thiophene (3ga). mp
182−184 °C (pale yellow powder), 69 mg (98%); 1H NMR (400
MHz, CDCl3) δ 2.96 (d, J = 0.8 Hz, 3H), 7.17−7.27 (m, 11H), 7.42
(ddd, J = 1.2 Hz, 6.8 Hz, 8.4 Hz, 1H), 7.60 (ddd, J =1.2, 6.8, 8.4 Hz,
1H), 7.70 (dd, J = 0.8, 8.4 Hz, 1H), 8.78 (d, J = 8.4 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 20.2, 123.3, 123.7, 124.8, 125.7, 126.6,
127.2, 127.6, 127.9, 128.0, 130.1, 130.2, 131.4, 131.9, 133.1, 134.2,
134.8, 135.0, 139.0, 139.7, 141.7; HRMS m/z Calcd for C25H18S (M+)
350.1129, found 350.1127.
</para>
Article
<para sub=“exp”>
1,2-Dimethyl-4,5-diphenylnaphtho[2,1-b]thiophene (3ha).
mp 245−247 °C (pale yellow powder), 71 mg (97%); 1H NMR
(400 MHz, CDCl3) δ 2.51 (s, 3H), 2.81 (s, 3H), 7.17−7.27 (m, 10H),
7.39 (ddd, J = 1.2, 7.2, 8.4 Hz, 1H), 7.57 (ddd, J = 1.2, 6.8, 8.4 Hz,
1H), 7.69 (d, J = 8.4 Hz, 1H), 8.81 (d, J = 8.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 14.1, 16.7, 123.2, 124.5, 125.4, 126.5, 127.1,
127.6, 127.8, 128.0, 129.8, 129.9, 130.0, 131.5, 132.0, 133.6, 133.8,
134.3, 134.7, 137.9, 139.2, 140.0; HRMS m/z Calcd for C26H20S (M+)
364.1286, found 364.1287.
Methyl 4,5-diphenylnaphtho[2,1-b]thiophene-2-carboxy-
late (3ia). mp 221−222 °C (white powder), 64 mg (81%); 1H
NMR (400 MHz, CDCl3) δ 3.92 (s, 3H), 7.17−7.30 (m, 10H), 7.46
(ddd, J = 1.2, 7.2, 8.4 Hz, 1H), 7.62−7.68 (m, 2H), 8.42 (d, J = 8.0 Hz,
1H), 8.78 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 52.4, 123.4, 126.1,
126.90, 126.97, 127.5, 127.7, 128.10, 128.14, 128.6, 129.3, 129.9,
131.2, 131.5, 132.8, 133.6, 134.7, 137.8, 138.2, 139.0, 143.6, 163.3;
HRMS m/z Calcd for C26H18O2S (M+) 394.1028, found 394.1025.
4,5-Diphenylanthra[2,1-b]thiophene (3ja). mp 200−203 °C
(white powder), 72 mg (93%); 1H NMR (400 MHz, CDCl3) δ 7.20−
7.33 (m, 10H), 7.42 (ddd, J = 1.2, 6.4, 8.0 Hz, 1H), 7.50 (ddd, J = 1.1,
6.4, 7.9 Hz, 1H), 7.57 (d, J = 5.2 Hz, 1H), 7.84 (d, J = 8.4 Hz, 1H),
8.07 (d, J = 8.0 Hz, 1H), 8.18 (s, 1H), 8.21 (d, J = 5.2 Hz, 1H), 8.89
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 121.6, 122.9, 125.1, 125.9,
126.2, 126.8, 127.1, 127.2, 127.5, 127.7, 127.8, 127.9, 128.6, 130.0,
130.6, 131.2, 131.5, 131.6, 133.4, 134.7, 135.0, 138.9, 139.6, 139.8;
HRMS m/z Calcd for C28H18S (M+) 386.1129, found 386.1128.
5,6-Diphenylbenzo[b]naphtho[1,2-d]thiophene (3ka):6 mp
205−206 °C (white powder), 27 mg (35%); 1H NMR (400 MHz,
CDCl3) δ 7.21−7.30 (m, 10H), 7.48 (t, J = 8.5 Hz, 2H), 7.61 (t, J =
7.7 Hz, 1H), 7.71−7.79 (m, 2H), 7.90 (d, J = 7.9 Hz, 1H), 8.91 (d, J =
8.4 Hz, 1H), 9.12 (d, J = 8.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
123.0, 123.1, 124.76, 124.82, 124.9, 125.2, 126.75, 126.83, 127.4,
127.7, 128.0, 128.57, 128.63, 130.1, 130.2, 131.3, 131.9, 134.1, 137.0,
137.4, 138.8, 139.7, 140.2, 141.1; HRMS m/z Calcd for C28H18S (M+)
386.1129, found 386.1125.
4,5-Dipropyl-7-(thiophen-3-yl)naphtho[2,1-b]thiophene
(3mj). mp 165−166 °C (white powder), 40 mg (57%); 1H NMR (400
MHz, CDCl3) δ 1.10−1.17 (m, 6H), 1.72−1.86 (m, 4H), 3.01−3.05
(m, 2H), 3.14−3.18 (m, 2H), 7.44−7.46 (m, 1H), 7.50 (d, J = 5.2 Hz,
1H), 7.53−7.57 (m, 2H), 7.78 (dd, J = 1.6, 8.4 Hz, 1H), 7.95 (d, J =
5.6 Hz, 1H), 8.29 (d, J = 1.6 Hz, 1H), 8.33 (d, J = 8.8 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 14.7, 14.8, 23.2, 24.5, 30.7, 35.4, 120.3,
122.4, 122.6, 124.1, 124.5, 124.7, 126.4, 126.6, 127.8, 131.0, 132.2,
132.59, 132.61, 134.3, 139.7, 143.0; HRMS m/z Calcd for C22H22S2
(M+) 350.1163, found 350.1160.
4,5,10,11-Tetrapropylanthra[2,1-b:6,5-b′]dithiophene (4mj).
mp 188−189 °C (pale yellow powder), 13 mg (14%); 1H NMR (400
MHz, CDCl3) δ 1.15 (t, J = 7.6 Hz, 6H), 1.22 (t, J = 7.6 Hz, 6H),
1.81−1.91 (m, 8H), 3.05−3.09 (m, 4H), 3.28−3.32 (m, 4H), 7.56 (d, J
= 5.4 Hz, 2H), 8.16 (d, J = 5.4 Hz, 2H), 9.04 (s, 2H); 13C NMR (100
MHz, CDCl3) δ 14.8, 14.9, 23.3, 24.4, 30.9, 35.4, 119.4, 122.8, 124.0,
126.9, 128.8, 131.68, 131.71, 134.4, 139.4; HRMS m/z Calcd for
C30H34S2 (M+) 458.2102, found 458.2098.
4,5-Dipropyl-8-(thiophen-3-yl)naphtho[2,1-b]thiophene
(3nj). mp 91−92 °C (brown powder), 20 mg (28%); 1H NMR (400
MHz, CDCl3) δ 1.10−1.16 (m, 6H), 1.69−1.86 (m, 4H), 3.00−3.06
(m, 2H), 3.10−3.14 (m, 2H), 7.45 (dd, J = 2.8, 5.2 Hz, 1H), 7.51 (d, J
= 5.2 Hz, 1H), 7.57 (dd, J = 1.6, 5.2 Hz, 1H), 7.61 (dd, J = 1.2, 2.8 Hz,
1H), 7.78 (dd, J = 1.6, 8.4 Hz, 1H), 8.01 (d, J = 5.6 Hz, 1H), 8.11 (d, J
= 8.8 Hz, 1H), 8.50 (d, J = 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3)
δ 14.7 (overlapped), 23.2, 24.5, 30.7, 35.3, 120.5, 121.3, 122.5, 124.1,
124.4, 125.5, 126.3, 126.6, 128.9, 129.8, 132.05, 132.07, 132.4, 134.4,
140.2, 142.5; HRMS m/z Calcd for C22H22S2 (M+) 350.1163, found
350.1164.
4,5,7,8-Tetrapropylanthra[2,1-b:7,8-b′]dithiophene (4nj). mp
152−153 °C (white powder), 32 mg (35%); 1H NMR (400 MHz,
CDCl3) δ 1.15 (t, J = 7.2 Hz, 6H), 1.23 (t, J = 7.2 Hz, 6H), 1.81−1.90
(m, 8H), 3.04−3.08 (m, 4H), 3.25−3.29 (m, 4H), 7.55 (d, J = 5.4 Hz,
2H), 8.19 (d, J = 5.4 Hz, 2H), 8.83 (s, 1H), 9.21 (s, 1H); 13C NMR
(100 MHz, CDCl3) δ 14.8, 15.0, 23.3, 24.5, 31.2, 35.5, 118.0, 120.9,
</para>
2811

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry
<para sub=“exp”>
123.0, 123.9, 126.6, 128.8, 131.3, 132.0, 134.0, 139.7; HRMS m/z
Calcd for C30H34S2 (M+) 458.2102, found 458.2103.
4,5-Diphenylbenzo[1,2-b:4,3-b′]dithiophene (3oa):22 mp
184−185 °C (white powder), 12 mg (9%); 1H NMR (400 MHz,
CDCl3) δ 7.23−7.34 (m, 10H), 7.54 (d, J = 5.4 Hz, 2H), 7.78 (d, J =
5.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 122.1, 127.2, 127.3,
128.1, 130.3, 131.4, 133.7, 139.36, 139.4; HRMS m/z Calcd for
C22H14S2 (M+) 342.0537, found 342.0538.
4,5-Diphenylbenzo[1,2-b:3,4-c′]dithiophene (3oa′). oil, 18 mg
(13%); 1H NMR (400 MHz, CDCl3) δ 7.19−7.31 (m, 10H), 7.43 (d, J
= 3.2 Hz, 1H), 7.46 (d, J = 5.3 Hz, 1H), 7.78 (d, J = 5.3 Hz, 1H), 7.91
(d, J = 3.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 114.0, 119.7,
123.1, 126.1, 126.8, 127.3, 127.9, 128.0, 130.0, 130.2, 130.8, 130.90,
130.94, 133.7, 138.7, 138.8, 139.1, 139.3; HRMS m/z Calcd for
C22H14S2 (M+) 342.0537, found 342.0539.
1,4,5-Triphenylnaphtho[2,1-b]thiophene (3pa). mp 188−190
°C (brown powder), 62 mg (75%); 1H NMR (400 MHz, CDCl3) δ
7.19−7.33 (m, 13H), 7.49−7.58 (m, 5H), 7.65 (d, J = 8.4 Hz, 1H),
7.93 (d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 123.9, 125.0,
125.3, 125.6, 126.7, 127.3, 127.65, 127.72, 127.9, 128.0, 128.6, 129.3,
130.0, 130.1, 131.4, 132.0, 132.3, 133.9, 135.3, 138.9, 139.2, 139.6,
140.5, 141.3; HRMS m/z Calcd for C30H20S (M+) 412.1286, found
412.1283.
5,6,8,9-Tetraphenyldinaphtho[2,1-b:1′,2′-d]thiophene (4pa).
mp 313−314 °C (white powder), 16 mg (13%); 1H NMR (400 MHz,
CDCl3) δ 7.17−7.30 (m, 20H), 7.48 (ddd, J = 1.2, 6.8, 8.0 Hz, 2H),
7.58 (ddd, J = 1.6, 6.8, 8.4 Hz, 2H), 7.77 (dd, J = 0.8, 8.4 Hz, 2H), 9.00
(d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 124.4, 125.3,
126.0, 126.8, 127.2, 127.6, 127.8, 128.0, 129.3, 130.2, 131.1, 131.4,
132.1, 133.8, 137.0, 138.7, 139.3, 141.2; HRMS m/z Calcd for C44H28S
(M+) 588.1912, found 588.1908.
1-Phenyl-4,5-dipropylnaphtho[2,1-b]thiophene (3pj). oil, 336
mg (98%); 1H NMR (400 MHz, CDCl3) δ 1.13−1.17 (m, 6H), 1.70−
1.89 (m, 4H), 3.04−3.08 (m, 2H), 3.11−3.15 (m, 2H), 7.16 (ddd, J =
1.2, 7.2, 8.4 Hz, 1H), 7.25 (s, 1H), 7.41−7.51 (m, 6H), 7.83 (d, J = 8.8
Hz, 1H), 8.08 (d, J = 8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
14.78, 14.80, 23.2, 24.3, 30.9, 35.2, 123.2, 124.2, 124.5, 124.78, 124.83,
127.5, 128.5, 129.2, 129.5, 131.28, 131.34, 132.1, 132.6, 139.5, 140.8,
141.0; HRMS m/z Calcd for C24H24S (M+) 344.1599, found 344.1597.
5,6,12,13-Tetraheptylnaphtho[2,1-b]naphtho[1′,2′:4,5]-
thieno[2,3-d]thiophene (4qk). mp 215−216 °C (pale yellow
powder), 124 mg (85%); 1H NMR (400 MHz, CDCl3) δ 0.90−0.95
(m, 12H), 1.32−1.52 (m, 24H), 1.54−1.65 (m, 8H), 1.70−1.78 (m,
4H), 1.82−1.90 (m, 4H), 3.10−3.19 (m, 8H), 7.62 (ddd, J = 1.2, 6.8,
8.4 Hz, 2H), 7.71 (ddd, J = 0.8, 6.8, 8.0 Hz, 2H), 8.18 (d, J = 8.0 Hz,
2H), 8.59 (dd, J = 1.2, 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ
14.1, 14.2, 22.7, 22.8, 28.9, 29.1, 29.2, 30.0, 30.3, 30.4, 31.3, 31.88,
31.93, 33.0, 124.9, 125.0, 125.3, 125.5, 127.3, 127.5, 131.0, 132.4,
133.0, 133.2, 142.5; HRMS m/z Calcd for C50H68S2 (M+) 732.4762,
found 732.4764.

5,6-Diphenylnaphtho[2,1-b]benzofuran (3ra):5a mp 213- 215
°C (white powder), 33 mg (90%); 1H NMR (400 MHz, CDCl3) δ
7.23−7.33 (m, 10H), 7.43−7.49 (m, 3H), 7.62−7.65 (m, 1H), 7.72
(ddd, J = 1.2, 6.8, 8.4 Hz, 1H), 7.78 (d, J = 7.6 Hz, 1H), 8.44−8.49 (m,
1H), 8.72 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 112.2,
116.8, 122.0, 123.2, 123.4, 124.5, 125.0, 125.9, 126.5, 126.87, 126.92,
127.1, 127.69, 127.73, 128.4, 128.7, 130.2, 131.0, 131.6, 135.5, 138.5,
138.8, 152.7, 156.0; HRMS m/z Calcd for C28H18O (M+) 370.1358,
found 370.1357.
4,5-Diphenylthieno[3,2-f ]quinoline (3ua). mp 200−203 °C
(yellow powder), 31 mg (47%); 1H NMR (400 MHz, CDCl3) δ 7.20−
7.31 (m, 10H), 7.51 (dd, J = 4.4, 8.4 Hz, 1H), 7.64 (d, J = 5.6 Hz, 1H),
8.06 (d, J = 5.6 Hz, 1H), 8.69 (dd, J = 1.6, 8.4 Hz, 1H), 8.94 (dd, J =
2.0, 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 120.8, 122.0, 123.8,
126.6, 127.3, 127.5, 127.7, 128.1, 129.8, 131.5, 131.9, 134.8, 135.8,
137.1, 138.1, 139.6, 140.1, 146.5, 149.2; HRMS m/z Calcd for
C23H15NS (M+) 337.0925, found 337.0927.
5,6-Diphenylthieno[2,3-h]isoquinoline (3ua′). mp 201−202
°C (white powder), 19 mg (27%); 1H NMR (400 MHz, CDCl3) δ
7.17−7.19 (m, 2H), 7.26−7.30 (m, 8H), 7.50 (d, J = 5.4 Hz, 1H), 7.72
</para>
Article
<para sub=“exp”>
(d, J = 5.5 Hz, 1H), 8.21 (d, J = 5.5 Hz, 1H), 8.54 (d, J = 5.8 Hz, 1H),
9.82 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 120.2, 121.3, 123.6,
127.2, 127.7, 127.9, 128.1, 128.7, 129.7, 131.4, 133.2, 134.67, 134.69,
137.2, 137.9, 139.0, 141.0, 143.7, 148.0; HRMS m/z Calcd for
C23H15NS (M+) 337.0925, found 337.0926.
4,5-Diphenylthieno[3,2-f ]isoquinoline (3va). mp 222−223 °C
(light brown powder), 58 mg (86%); 1H NMR (400 MHz, CDCl3) δ
7.20−7.31 (m, 10H), 7.64 (d, J = 5.2 Hz, 1H), 8.06 (d, J = 5.6 Hz,
1H), 8.14 (dd, J = 0.8, 5.6 Hz, 1H), 8.68 (d, J = 5.6 Hz, 1H), 9.06 (s,
1H); 13C NMR (100 MHz, CDCl3) δ 116.4, 122.2, 126.3, 127.2,
127.60, 127.65, 127.8, 128.1, 129.8, 131.4, 131.8, 133.7, 134.3, 135.0,
136.8, 138.9, 143.6, 143.8, 152.0; HRMS m/z Calcd for C23H15NS
(M+) 337.0925, found 337.0923.
4,5-Diphenylthieno[2′,3′:5,6]benzo[1,2-g]quinoline (3wa).
mp 272−273 °C (pale yellow powder), 55 mg (70%); 1H NMR
(400 MHz, CDCl3) δ 7.23−7.33 (m, 10H), 7.39 (dd, J = 4.0, 8.4 Hz,
1H), 7.62 (d, J = 5.2 Hz, 1H), 8.20 (d, J = 5.2 Hz, 1H), 8.37 (d, J = 8.4
Hz, 1H), 8.52 (s, 1H), 8.84 (s, 1H), 8.92 (dd, J = 1.6, 4.0 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 120.9, 121.8, 122.9, 126.3, 126.7, 127.0,
127.4, 127.7, 127.9, 128.0, 128.4, 129.9, 131.5, 133.3, 134.4, 134.7,
134.9, 135.9, 138.3, 139.5, 140.2, 144.7, 150.9; HRMS m/z Calcd for
C27H17NS (M+) 387.1082, found 387.1078.
2,4,5-Triphenylnaphtho[2,1-d]thiazole (3xa). mp 262−264 °C
(white powder), 62 mg (75%); 1H NMR (400 MHz, CDCl3) δ 7.21−
7.31 (m, 10H), 7.45−7.51 (m, 4H), 7.66−7.70 (m, 2H), 8.15−8.18
(m, 2H), 9.02 (dd, J =1.2, 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3)
δ 124.1, 126.3, 126.6, 126.9, 127.2, 127.3, 127.4, 127.7, 128.1
(overlapped), 129.0, 129.7, 130.5, 131.5, 132.2, 132.4, 134.0, 134.5,
135.8, 138.4, 140.5, 150.0, 167.3; HRMS m/z Calcd for C29H19NS
(M+) 413.1238, found 413.1239.
2-Methyl-4,5-diphenylnaphtho[1,2-d]thiazole (3ya). mp
258−260 °C (white powder), 55 mg (78%); 1H NMR (400 MHz,
CDCl3) δ 2.90 (s, 3H), 7.18−7.30 (m, 10H), 7.46 (ddd, J = 1.6, 7.2,
8.4 Hz, 1H), 7.63−7.69 (m, 2H), 8.86 (d, J = 8.3 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 20.1, 123.8, 126.1, 126.5, 126.8, 127.2, 127.3,
127.6, 127.7, 128.0, 129.6, 131.5, 132.0, 132.3, 134.7, 135.1, 138.5,
140.6, 148.6, 166.5; HRMS m/z Calcd for C24H17NS (M+) 351.1082,
found 351.1079.
2,4,5-Triphenylnaphtho[1,2-d]oxazole (3bba). mp 207−208
°C (white powder), 61 mg (76%); 1H NMR (400 MHz, CDCl3) δ
7.23−7.34 (m, 10H), 7.42−7.50 (m, 4H), 7.66 (ddd, J = 1.2, 6.8, 8.0
Hz, 1H), 7.73 (d, J = 8.8 Hz, 1H), 8.25−8.27 (m, 2H), 8.68 (d, J = 8.0
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 122.2, 124.8, 125.6, 125.9,
126.6, 127.0, 127.2, 127.38, 127.41, 127.78, 127.81, 127.9, 128.8,
130.7, 131.0, 131.1, 131.7, 135.1, 136.2, 137.1, 138.3, 146.9, 162.5;
HRMS m/z Calcd for C29H19NO (M+) 397.1467, found 397.1466.
5,6-Diphenylnaphtho[2,1-b]benzofuran (3cca). mp 233−235
°C (yellow powder), 30 mg (44%); 1H NMR (400 MHz, CDCl3) δ
2.72 (s, 3H), 7.20−7.33 (m, 10H), 7.42 (ddd, J =1.2, 6.8, 8.4 Hz, 1H),
7.64 (ddd, J = 1.2, 6.8, 8.0 Hz, 1H), 7.70 (d, J = 8.4 Hz, 1H), 8.54 (d, J
= 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.8, 121.9, 124.7,
125.3, 125.6, 126.6, 127.0, 127.2, 127.74, 127.78, 127.82, 130.6, 130.8,
131.7, 135.1, 135.6, 136.0, 138.3, 147.0, 163.2; HRMS m/z Calcd for
C24H17NO (M+) 335.1310, found 335.1313.

(E)-Butyl 3-[2-(thiophen-3-yl)phenyl]acrylate (6aa):6 oil, 34
mg (60%); 1H NMR (400 MHz, CDCl3) δ 0.95 (t, J = 7.2 Hz, 3H),
1.36−1.46 (m, 2H), 1.62−1.69 (m, 2H), 4.17 (t, J = 6.6 Hz, 2H), 6.39
(d, J = 15.9 Hz, 1H), 7.14−7.16 (m, 1H), 7.23−7.24 (m, 1H), 7.33−
7.44 (m, 4H), 7.66 (d, J = 7.1 Hz, 1H), 7.87 (d, J = 16.0 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ 13.7, 19.2, 30.7, 64.3, 119.4, 124.2, 125.7,
126.9, 127.6, 129.1, 129.8, 130.2, 132.9, 137.4, 140.4, 143.7, 167.0;
HRMS m/z Calcd for C17H18O2S (M+) 286.1028, found 286.1027.

(E)-Isobutyl 3-(2-(thiophen-3-yl)phenyl)acrylate (6ab). oil, 28
mg (50%); 1H NMR (400 MHz, CDCl3) δ 0.94 (s, 3H), 0.96 (s, 3H),
1.97 (m, 1H), 3.96 (d, J = 6.6 Hz, 2H), 6.41 (d, J = 16.0 Hz, 1H), 7.15
(dd, J = 1.2, 4.8 Hz, 1H), 7.23 (dd, J = 1.2, 2.8 Hz, 1H), 7.33−7.44 (m,
4H), 7.68 (d, J = 7.4 Hz, 1H), 7.88 (d, J = 16.0 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 19.1, 27.8, 70.5, 119.4, 124.2, 125.7, 126.9,
127.6, 129.1, 129.8, 130.1, 132.9, 137.3, 140.3, 143.7, 166.9; HRMS m/
z Calcd for C17H18O2S (M+) 286.1028, found 286.1026.
</para>
2812

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry

Article
<para sub=“exp”>
(E)-tert-Butyl 3-(2-(thiophen-3-yl)phenyl)acrylate (6ac). oil,
30 mg (52%); 1H NMR (400 MHz, CDCl3) δ 1.50 (s, 9H), 6.34 (d, J
= 16.0 Hz, 1H), 7.15 (dd, J = 1.2, 4.8 Hz, 1H), 7.23 (dd, J = 1.3, 3.0
Hz, 1H), 7.32−7.43 (m, 4H), 7.67 (d, J = 7.8 Hz, 1H), 7.79 (d, J =
16.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 28.2, 80.4, 121.1, 124.1,
125.6, 126.7, 127.5, 129.1, 129.6, 130.1, 132.9, 137.3, 140.4, 142.5,
166.2; HRMS m/z Calcd for C17H18O2S (M+) 286.1028,
found
286.1026.

(E)-Ethyl 3-(2-(thiophen-3-yl)phenyl)acrylate (6ad). oil, 24 mg
(47%); 1H NMR (400 MHz, CDCl3) δ 1.31 (t, J = 7.1 Hz, 3H), 4.23
(q, J = 7.1 Hz, 2H), 6.39 (d, J = 15.9 Hz, 1H), 7.15 (dd, J = 1.6, 5.2
Hz, 1H), 7.23 (dd, J = 1.6, 3.2 Hz, 1H), 7.33−7.44 (m, 4H), 7.66 (d, J
= 8.0 Hz, 1H), 7.87 (d, J = 16.0 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 14.3, 60.4, 119.4, 124.2, 125.7, 126.9, 127.6, 129.1, 129.8,
130.2, 132.9, 137.4, 140.3, 143.8, 166.9; HRMS m/z Calcd for
C15H14O2S (M+) 258.0715, found 258.0714.
(E)-Cyclohexyl 3-(2-(thiophen-3-yl)phenyl)acrylate (6ae). oil,
40 mg (64%); 1H NMR (400 MHz, CDCl3) δ 1.26−1.57 (m, 6H),
1.71−1.75 (m, 2H), 1.85−1.89 (m, 2H), 4.84−4.90 (m, 1H), 6.39 (d, J
= 15.6 Hz, 1H), 7.15 (dd, J = 1.6, 5.2 Hz, 1H), 7.24 (dd, J = 1.2, 2.8
Hz, 1H), 7.33−7.44 (m, 4H), 7.67 (d, J = 7.8 Hz, 1H), 7.87 (d, J =
15.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 23.6, 25.4, 31.6, 72.5,
120.0, 124.2, 125.7, 126.9, 127.6, 129.2, 129.7, 130.1, 133.0, 137.4,
140.4, 143.5, 166.3; HRMS m/z Calcd for C19H20O2S (M+) 312.1184,
found 312.1182.

(E)-Diethyl 2-(thiophen-3-yl)styrylphosphonate (6ag). oil, 30
mg (47%); 1H NMR (400 MHz, CDCl3) δ 1.32 (dd, J = 0.4, 6.8 Hz,
6H), 4.10 (qd, J = 7.2, 14.4 Hz, 4H), 6.23 (dd, J = 17.6, 18.8 Hz, 1H),
7.13 (dd, J = 1.6, 5.2 Hz, 1H), 7.22 (dd, J = 1.2, 2.8 Hz, 1H), 7.34−
7.41 (m, 4H), 7.55−7.65 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
16.4 (d, J = 6.5 Hz), 61.7 (d, J = 5.6 Hz), 115.5 (d, J = 190.0 Hz),
124.1, 125.7, 126.7 (d, J = 1.24 Hz), 127.6, 129.0, 129.8, 130.2 (d, J =
1.3 Hz), 133.4 (d, J = 22.7 Hz), 137.0, 140.3, 147.2 (d, J = 7.0 Hz);
HRMS m/z Calcd for C16H19O3PS (M+) 322.0793, found 322.0795.
(E)-3-(2-Styrylphenyl)thiophene (6ah):6 oil, 30 mg (58%); 1H
NMR (400 MHz, CDCl3) δ 7.03 (d, J = 16.4 Hz, 1H), 7.21−7.43 (m,
12H), 7.71 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 123.6,
125.2, 126.1, 126.5, 127.5 (overlapped), 127.6, 127.9, 128.7, 129.4,
129.7, 129.9, 135.75, 135.77, 137.5, 141.3; HRMS m/z Calcd for
C18H14S (M+) 262.0816, found 262.0813.

(E)-3-(2-(4-Methylstyryl)phenyl)thiophene (6ai). oil, 30 mg
(53%); 1H NMR (400 MHz, CDCl3) δ 2.96 (s, 3H), 7.00 (d, J = 16.4
Hz, 1H), 7.13−7.40 (m, 11H), 7.70 (d, J = 7.6 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 21.2, 123.5, 125.1, 126.0, 126.4, 126.9, 127.3,
127.5, 129.3, 129.4, 129.7, 129.9, 134.8, 135.6, 135.9, 137.4, 141.4;
HRMS m/z Calcd for C19H16S (M+) 276.0973, found 276.0975.

(E)-3-(2-(4-(tert-Butyl)styryl)phenyl)thiophene (6aj). oil, 29
mg (45%); 1H NMR (400 MHz, CDCl3) δ 1.32 (s, 9H), 7.01 (d, J
= 16.4 Hz, 1H), 7.19−7.23 (m, 2H), 7.27−7.40 (m, 9H), 7.71 (d, J =
7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 31.3, 34.6, 123.6, 125.1,
125.6, 126.1, 126.3, 127.2, 127.4, 127.5, 129.4, 129.5, 129.9, 134.8,
135.6, 136.0, 141.4, 150.7; HRMS m/z Calcd for C22H22S (M+)
318.1442, found 318.1441.

(E)-3-(2-(4-Methoxystyryl)phenyl)thiophene (6ak). oil, 31 mg
(53%); 1H NMR (400 MHz, CDCl3) δ 3.81 (s, 3H), 6.87 (d, J = 8.8
Hz, 2H), 6.98 (d, J = 16.0 Hz, 1H), 7.10 (d, J = 16.4 Hz, 1H), 7.21
(dd, J = 1.6, 5.2 Hz, 1H), 7.27−7.39 (m, 7H), 7.69 (d, J = 7.7 Hz, 1H);
13C NMR (100 MHz, CDCl3) δ 55.3, 114.1, 123.5, 125.1, 125.8, 125.9,
127.2, 127.5, 127.7, 129.2, 129.4, 129.9, 130.4, 135.5, 136.1, 141.5,
159.2; HRMS m/z Calcd for C19H16OS (M+) 292.0922,
found
292.0921.
(E)-3-(2-(2-([1,1′-Biphenyl]-4-yl)vinyl)phenyl)thiophene (6al).
oil, 44 mg (65%); 1H NMR (400 MHz, CDCl3) δ 7.07 (d, J = 16.0 Hz,
1H), 7.22−7.61 (m, 12H), 7.56−7.61 (m, 4H), 7.74 (d, J = 7.4 Hz,
1H); 13C NMR (100 MHz, CDCl3) δ 123.6, 125.2, 126.1, 126.9,
127.0, 127.30, 127.34, 127.57, 127.58, 128.0, 128.8, 129.2, 129.4,
130.0, 135.8 (overlapped), 136.6, 140.3, 140.6, 141.4; HRMS m/z
Calcd for C24H18S (M+) 338.1124, found 338.1131.

(E)-3-(2-(4-Chlorostyryl)phenyl)thiophene (6am). oil, 38 mg
(63%); 1H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 16.0 Hz, 1H),

7.18−7.41 (m, 11H), 7.69 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 123.6, 125.3, 126.1, 127.6, 127.7, 127.8, 128.4, 128.5, 128.8,
129.4, 130.0, 133.1, 135.4, 135.8, 136.0, 141.3; HRMS m/z Calcd for
C18H13ClS (M+) 296.0426, found 296.0426.

(E)-3-(2-(4-(triﬂuoromethyl)styryl)phenyl)thiophene (6an).
oil, 41 mg (63%); 1H NMR (400 MHz, CDCl3) δ 7.04 (d, J = 16.0
Hz, 1H), 7.19 (dd, J = 1.6, 5.2 Hz, 1H), 7.27 (dd, J = 1.2, 3.2 Hz, 1H),
7.30−7.43 (m, 5H), 7.49 (d, J = 8.4 Hz, 2H), 7.57 (d, J = 9.2 Hz, 2H),
7.71−7.73 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 123.7, 124.2 (q, J
= 270.0 Hz), 125.4, 125.6 (q, J = 3.8 Hz), 126.2, 126.6, 127.7, 128.1
(overlapped), 129.2 (q, J = 32.6 Hz), 129.3, 130.1, 130.4, 135.1, 136.1,
140.9, 141.1; HRMS m/z Calcd for C19H13F3S (M+) 330.0690, found
330.0692.

(E)-3-(2-(2-(Naphthalen-2-yl)vinyl)phenyl)thiophene (6ao).
oil, 31 mg (50%); 1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 16.4
Hz, 1H), 7.24 (dd, J = 1.2, 4.8 Hz, 1H), 7.31−7.48 (m, 8H), 7.60 (dd,
J = 1.6, 8.4 Hz, 1H), 7.76−7.82 (m, 5H);13C NMR (100 MHz,
CDCl3) δ 123.5, 123.6, 125.3, 125.9, 126.1, 126.3, 126.6, 127.59,
127.60, 127.7, 128.0, 128.2, 128.3, 129.4, 129.8, 130.0, 132.9, 133.6,
135.1, 135.8 (overlapped), 141.4; HRMS m/z Calcd for C22H16S (M+)
312.0973, found 312.0971.
2,3,6,7-Tetramethoxybenzo[b]benzo[11,12]chryseno[6,5-d]-
thiophene (7). mp 235−236 °C (yellow powder), 14 mg (59%); 1H
NMR (400 MHz, CDCl3) δ 4.01 (s, 3H), 4.17 (s, 3H), 4.19 (s, 3H),
4.20 (s, 3H), 7.51 (t, J = 7.6 Hz, 1H), 7.59−7.64 (m, 2H), 7.73 (tdd, J
= 1.2, 7.2, 8.4 Hz, 1H), 7.86 (s, 1H), 7.91 (s, 1H), 8.05 (d, J = 8.0 Hz,
1H), 8.25 (s, 1H), 8.71 (s, 1H), 8.83 (d, J = 8.0 Hz, 1H), 8.90 (d, J =
8.4 Hz, 1H), 9.01 (d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
56.07, 56.13, 56.2, 56.4, 104.1, 104.3, 107.7, 111.1, 122.5, 123.1, 123.3,
123.9, 124.0, 124.2, 124.5, 124.9, 125.07, 125.12, 125.14, 126.6, 127.2,
128.4, 129.1, 129.36, 129.4, 134.9, 135.9, 139.5, 148.2, 149.1, 149.2
(overlapped); HRMS (APCI) m/z Calcd for C32H25O4S ([M + H]+)
505.1468, found 505.1467.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
Results for H/D exchange experiments and copies of 1H and
13C NMR spectra of products. This material is available free of
charge via the Internet at http://pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: satoh@chem.eng.osaka-u.ac.jp.
*E-mail: miura@chem.eng.osaka-u.ac.jp.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

This work was supported by Grants-in-Aid from MEXT, JSPS,
and JST, Japan.

■ REFERENCES

(1) For recent reviews, see: (a) Sista, P.; Biewer, M. C.; Stefan, M. C.
Macromol. Rapid Commun. 2012, 33, 9. (b) Takimiya, K.; Shinamura,
S.; Osaka, I.; Miyazaki, E. Adv. Mater. 2011, 23, 4347. (c) Wu, W.; Liu,
Y.; Zhu, D. Chem. Soc. Rev. 2010, 39, 1489. (d) Chen, J.; Cao, A. Y.
Acc. Chem. Res. 2009, 42, 1709. (e) Allard, S.; Forster, M.; Souharce,
B.; Thiem, H.; Scherf, U. Angew. Chem., Int. Ed. 2008, 47, 4070.
(f) Ong, B. S.; Wu, Y.; Li, Y.; Liu, P.; Pan, H. Chem.Eur. J. 2008, 14,
4766. (g) Murphy, A. R.; Fréchet, J. M. J. Chem. Rev. 2007, 107, 1066.
(h) Takimiya, K.; Kunugi, Y.; Otsubo, T. Chem. Lett. 2007, 36, 578.
(i) Anthony, J. E. Chem. Rev. 2006, 106, 5028. (j) Roncali, J.;
Blanchard, P.; Frere, P. J. Mater. Chem. 2005, 15, 1589. (k) Katz, H. E.;
Bao, Z.; Gilat, S. L. Acc. Chem. Res. 2001, 34, 359.
(2) For recent examples, see: (a) Lindert, S.; Zhu, W.; Liu, Y.-L.;
Pang, R.; Oldfield, E.; McCammon, J. A. Chem. Biol. Drug Des. 2013,
81, 742. (b) Jahnke, W.; Rondeau, J.-M.; Cotesta, S.; Marzinzik, A.;

2813

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

The Journal of Organic Chemistry
Pellé, X.; Geiser, M.; Strauss, A.; Götte, M.; Bitsch, F.; Hemmig, R.;
Henry, C.; Lehmann, S.; Glickman, J. F.; Roddy, T. P.; Stout, S. J.;
Green, J. R. Nat. Chem. Biol. 2010, 6, 660. (c) Hranjec, M.; Starcevic,
K.; Piantanida, I.; Kralj, M.; Marjanovic, M.; Hasani, M.; Westman, G.;
Zamola, G. K. Eur. J. Med. Chem. 2008, 43, 2877. (d) Ferri, N.;
Beccalli, E. M.; Contini, A.; Corsini, A.; Antonino, M.; Radice, T.;
Pratesi, G.; Tinelli, S.; Zunino, F.; Gelmi, M. L. Bioorg. Med. Chem.
2008, 16, 1691.
(3) For selected recent reviews of C−H functionalization, see:
(a) Jin, T.; Zhao, J.; Asao, N.; Yamamoto, Y. Chem.Eur. J. 2014, 20,
3554. (b) De Sarkar, S.; Liu, W.; Kozhushkov, S. I.; Ackermann, L.
Adv. Synth. Catal. 2014, 356, 1461. (c) Kuhl, N.; Schröder, N.; Glorius,
F. Adv. Synth. Catal. 2014, 356, 1443. (d) Shi, G.; Zhang, Y. Adv. Synth.
Catal. 2014, 356, 1419. (e) Bonin, H.; Sauthier, M.; Felpin, F.-X. Adv.
Synth. Catal. 2014, 356, 645. (f) Engle, K. M.; Yu, J.-Q. J. Org. Chem.
2013, 78, 8927. (g) Wencel-Delord, J.; Glorius, F. Nat. Chem. 2013, 5,
369. (h) Colby, D. A.; Tsai, A. S.; Bergman, R. G.; Ellman, J. A. Acc.
Chem. Res. 2012, 45, 814. (i) Engle, K. M.; Mei, T.-S.; Wasa, M.; Yu, J.-
Q. Acc. Chem. Res. 2012, 45, 788. (j) Mitchell, E. A.; Peschiulli, A.;
Lefevre, N.; Meerpoel, L.; Maes, B. U. W. Chem.Eur. J. 2012, 18,
10092. (k) Cho, S. H.; Kim, J. Y.; Kwak, J.; Chang, S. Chem. Soc. Rev.
2011, 40, 5068. (l) Wencel-Delord, J.; Droge, T.; Liu, F.; Glorius, F.
Chem. Soc. Rev. 2011, 40, 4740. (m) Kuninobu, Y.; Takai, K. Chem.
Rev. 2011, 111, 1938. (n) Liu, C.; Zhang, H.; Shi, W.; Lei, A. Chem.
Rev. 2011, 111, 1780. (o) Ackermann, L. Chem. Rev. 2011, 111, 1315.
(p) Lapointe, D.; Fagnou, K. Chem. Lett. 2010, 39, 1118. (q) Lyons, T.
W.; Sanford, M. S. Chem. Rev. 2010, 110, 1147. (r) Colby, D. A.;
Bergman, R. G.; Ellman, J. A. Chem. Rev. 2010, 110, 624. (s) Sun, C.-
L.; Li, B.-J.; Shi, Z.-J. Chem. Commun. 2010, 46, 677. (t) Satoh, T.;
Miura, M. Chem.Eur. J. 2010, 16, 11212. (u) Satoh, T.; Miura, M.
Synthesis 2010, 3395. (v) Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-
Q. Angew. Chem., Int. Ed. 2009, 48, 5094. (w) Daugulis, O.; Do, H.-Q.;
Shabashov, D. Acc. Chem. Res. 2009, 42, 1074. (x) McGlacken, G. P.;
Bateman, L. M. Chem. Soc. Rev. 2009, 38, 2447. (y) Li, C.-J. Acc. Chem.
Res. 2009, 42, 335. (z) Kakiuchi, F.; Kochi, T. Synthesis 2008, 3013.
(aa) Ferreira, E. M.; Zhang, H.; Stoltz, B. M. Tetrahedron 2008, 64,
5987. (bb) Park, Y. J.; Park, J.-W.; Jun, C.-H. Acc. Chem. Res. 2008, 41,
222. (cc) Beccalli, E. M.; Broggini, G.; Martinelli, M.; Sottocornola, S.
Chem. Rev. 2007, 107, 5318. (dd) Alberico, D.; Scott, M. E.; Lautens,
M. Chem. Rev. 2007, 107, 174. (ee) Godula, K.; Sames, D. Science
2006, 312, 67. (ff) Kakiuchi, F.; Chatani, N. Adv. Synth. Catal. 2003,
345, 1077. (gg) Dyker, G. Angew. Chem., Int. Ed. 1999, 38, 1698.
(4) For selected examples, see: (a) Gandeepan, P.; Cheng, C.-H. Org.
Lett. 2013, 15, 2084. (b) Minami, Y.; Shiraishi, Y.; Yamada, K.;
Hiyama, T. J. Am. Chem. Soc. 2012, 134, 6124. (c) Gandeepan, P.;
Cheng, C.-H. J. Am. Chem. Soc. 2012, 134, 5738. (d) Chernyak, N.;
Gorelsky, S. I.; Gevorgyan, V. Angew. Chem., Int. Ed. 2011, 50, 2342.
(e) Chernyak, N.; Gevorgyan, V. J. Am. Chem. Soc. 2008, 130, 5636.
(f) Tobisu, M.; Hyodo, I.; Onoe, M.; Chatani, N. Chem. Commun.
2008, 6013. (g) Yamada, S.; Obora, Y.; Sakaguchi, S.; Ishii, Y. Bull.
Chem. Soc. Jpn. 2007, 80, 1194. (h) Kiyooka, S.-i.; Takeshita, Y.
Tetrahedron Lett. 2005, 46, 4279. (i) Iverson, C. N.; Lachicotte, R. J.;
Müller, C.; Jones, W. D. Organometallics 2002, 21, 5320. (j) Tanaka,
K.; Fu, G. C. Org. Lett. 2002, 4, 933. (k) Kakiuchi, F.; Sonoda, M.;
Tsujimoto, T.; Chatani, N.; Murai, S. Chem. Lett. 1999, 28, 1083. See
also a recent review: (l) Gandeepan, P.; Cheng, C.-H. Chem. Asian J.
2015, DOI: 10.1002/asia.201403224.
(5) (a) Shi, Z.; Ding, S.; Cui, Y.; Jiao, N. Angew. Chem., Int. Ed. 2009,
48, 7895. (b) Morimoto, K.; Hirano, K.; Satoh, T.; Miura, M. Org. Lett.
2010, 12, 2068. (c) Umeda, N.; Hirano, K.; Satoh, T.; Shibata, N.;
Sato, H.; Miura, M. J. Org. Chem. 2011, 76, 13. (d) Huang, J.-R.;
Zhang, Q.-R.; Qu, C.-H.; Sun, X.-H.; Dong, L.; Chen, Y.-C. Org. Lett.
2013, 15, 1878. (e) Huang, J.-R.; Dong, L.; Han, B.; Peng, C.; Chen,
Y.-C. Chem.Eur. J. 2012, 18, 8896.
(6) For preliminary communication, see: Iitsuka, T.; Hirano, K.;
Satoh, T.; Miura, M. Chem.Eur. J. 2014, 20, 385.
(7) For selected examples of RhIII-catalyzed C−H functionalization,
see: (a) Tauchert, M. E.; Incarvito, C. D.; Reingold, A. L.; Bergman, R.
G.; Ellman, J. A. J. Am. Chem. Soc. 2012, 134, 1482. (b) Wang, P. H.

Article

R.; Hua, R.; Li, C.-J. Org. Lett. 2012, 14, 902. (c) Jayakumar, J.;
Parthasarathy, K.; Cheng, C.-H. Angew. Chem., Int. Ed. 2012, 51, 197.
(d) Li, H.; Li, Y.; Zhang, X.-S.; Chen, K.; Wang, X.; Shi, Z.-J. J. Am.
Chem. Soc. 2011, 133, 15244. (e) Wei, X.; Zhao, M.; Du, Z.; Li, X. Org.
Lett. 2011, 13, 4636. (f) Hyster, T. K.; Rovis, T. Chem. Sci. 2011, 2,
1606. (g) Wang, Y.-F.; Toh, K. K.; Lee, J.-Y.; Chiba, S. Angew. Chem.,
Int. Ed. 2011, 50, 5927. (h) Park, S. H.; Kim, J. Y.; Chang, S. Org. Lett.
2011, 13, 2372. (i) Guimond, N.; Gorelsky, S. I.; Fagnou, K. J. Am.
Chem. Soc. 2011, 133, 6449. (j) Patureau, F. W.; Besset, T.; Kuhl, N.;
Glorius, F. J. Am. Chem. Soc. 2011, 133, 2154. (k) Stuart, D. R.;
Alsabeh, P.; Kuhn, M.; Fagnou, K. J. Am. Chem. Soc. 2010, 132, 18326.
(l) Li, L.; Brennessel, W. W.; Jones, W. D. J. Am. Chem. Soc. 2008, 130,
12414.
(8) Yang, S.-M.; Shie, J.-J.; Fang, J.-M.; Nandy, S. K.; Chang, H.-Y.;
Lu, S.-H.; Wang, G. J. Org. Chem. 2002, 67, 5208.
(9) Bancerz, M.; Huck, L. A.; Leigh, W. J.; Mladenove, G.; Najaflan,
K.; Zeng, X.; Lee-Ruff, E. J. Phys. Org. Chem. 2010, 23, 1202.
(10) Chasset, S.; Chevreuil, F.; Ledoussal, B.; Le Strat, F.; Benarous,
R. WO2012137181 A1, 2012.
(11) Toyota, K.; Goto, Y.; Okada, K.; Morita, N. Heterocycles 2007,
71, 2227.
(12) Moure, M. J.; SanMartin, R.; Dominguez, E. Angew. Chem. Ind.
Ed. 2012, 51, 3220.
(13) Zhu, D.; Chen, J.; Xiao, H.; Liu, M.; Ding, J.; Wu, H. Synth.
Commun. 2009, 39, 2895.
(14) Yokooji, A.; Okazawa, T.; Satoh, T.; Miura, M.; Nomura, M.
Tetrahedron 2003, 59, 5685.
(15) Saito, A.; Taniguchi, A.; Kambara, Y.; Hanzawa, Y. Org. Lett.
2013, 15, 2672.
(16) Varma, R. S.; Kumar, D. J. Heterocycl. Chem. 1998, 35, 1533.
(17) Novak, Z.; Nemes, P.; Kotschy, A. Org. Lett. 2004, 6, 4917.
(18) Finke, A. D.; Dumele, O.; Zalibera, M.; Confortin, D.; Cias, P.;
Jayamurugan, G.; Gisselbrecht, J.-P.; Boudon, C.; Schweizer, W. B.;
Gescheidt, G.; Diederich, F. J. Am. Chem. Soc. 2012, 134, 18139.
(19) Mio, M. J.; Kopel, L. C.; Braun, J. B.; Gadzikwa, T. L.; Hull, K.
L.; Brisbois, R. G.; Markworth, C. J.; Grieco, P. A. Org. Lett. 2002, 4,
3199.
(20) Schmidt, B.; Berger, R.; Kelling, A.; Schilde, U. Chem.Eur. J.
2011, 17, 7032.
(21) McCarthy, T. D.; Naylor, A. WO2013102242 A1, 2013.
(22) Shimizu, M.; Nagao, I.; Tomioka, Y.; Hiyama, T. Angew. Chem.,
Int. Ed. 2008, 47, 8096.

2814

DOI: 10.1021/acs.joc.5b00155
J. Org. Chem. 2015, 80, 2804−2814

